Modified bovine serum albumin as an effective charge-reversal platform for simultaneously improving the transfection efficiency and biocompatibility of polyplexes.

The charge-reversal strategy is usually employed in gene delivery to facilitate the endosomal escape of gene carriers and the release of the payload into cytoplasm. However, most of the charge-reversal materials are far from perfect biocompatible materials due to the cytotoxicity of themselves or their hydrolyzed products. In this study, an excellent charge-reversal material named modified bovine serum albumin (mBSA) was prepared. The charge reversal of biocompatible mBSA is a physical process and can instantly occur, which was confirmed by zeta potential, size detection and morphological studies. The introduction of mBSA can not only reduce the zeta potential of binary complexes (pDNA-PEI) but also increase the nuclease resistance ability of the pDNA-PEI binary complexes. In addition, cell viabilities tested by MTT assay and gene transfection assay demonstrated that mBSA can reduce the cytotoxicity of pDNA-PEI polyplexes and improve their gene transfection efficiency (serum free and 10% FBS medium) both in 293T and HepG2 cells at the same time. The experimental results of cell internalization and intracellular distribution of pDNA-PEI-mBSA ternary complexes confirmed that the improvement of transfection efficiency originated from the enhancement of endosomal escape of polyplexes. Therefore, mBSA has been proven to be a perfect charge-reversal platform to simultaneously improve the transfection efficiency and biocompatibility of polyplexes.

[1]  Xing-jie Liang,et al.  Polycations with excellent gene transfection ability based on PVP-g-PDMAEMA with random coil and micelle structures as non-viral gene vectors. , 2015, Journal of materials chemistry. B.

[2]  Ravi Sundaram,et al.  Combinatorial approach in the design of multifunctional polymeric nano-delivery systems for cancer therapy. , 2014, Journal of materials chemistry. B.

[3]  Z. Gu,et al.  Influence of reduction-sensitive diselenide bonds and disulfide bonds on oligoethylenimine conjugates for gene delivery. , 2014, Journal of materials chemistry. B.

[4]  Qing Jiang,et al.  PEGylated poly(amine-co-ester) micelles as biodegradable non-viral gene vectors with enhanced stability, reduced toxicity and higher in vivo transfection efficacy. , 2014, Journal of materials chemistry. B.

[5]  S. Lippard,et al.  Pt(IV) Prodrugs Designed to Bind Non-Covalently to Human Serum Albumin for Drug Delivery , 2014, Journal of the American Chemical Society.

[6]  Xun Sun,et al.  Cationic bovine serum albumin based self-assembled nanoparticles as siRNA delivery vector for treating lung metastatic cancer. , 2014, Small.

[7]  Amanda C. Engler,et al.  Mitigated Cytotoxicity and Tremendously Enhanced Gene Transfection Efficiency of PEI through Facile One‐Step Carbamate Modification , 2013, Advanced healthcare materials.

[8]  K. Kinzler,et al.  A nanoparticle formulation that selectively transfects metastatic tumors in mice , 2013, Proceedings of the National Academy of Sciences.

[9]  Jinfeng Xing,et al.  A kind of modified bovine serum albumin with great potential for applying in gene delivery , 2013 .

[10]  Zhongdang Xiao,et al.  PEGylated denatured bovine serum albumin modified water-soluble inorganic nanocrystals as multifunctional drug delivery platforms. , 2013, Journal of materials chemistry. B.

[11]  Biao Zhang,et al.  Ternary Complexes of Poly(Vinyl Pyrrolidone)-Graft-Poly(2-Dimethylaminoethyl Methacrylate), DNA and Bovine Serum Albumin for Gene Delivery , 2012, Journal of biomaterials science. Polymer edition.

[12]  Wenjun Yang,et al.  Disulfide cross-linked low generation dendrimers with high gene transfection efficacy, low cytotoxicity, and low cost. , 2012, Journal of the American Chemical Society.

[13]  Lorenzo Moroni,et al.  Cationic polymers and their therapeutic potential. , 2012, Chemical Society reviews.

[14]  Pekka Hänninen,et al.  Method for estimation of protein isoelectric point. , 2012, Analytical chemistry.

[15]  Xu Zhang,et al.  Enhanced siRNA delivery and silencing gold-chitosan nanosystem with surface charge-reversal polymer assembly and good biocompatibility. , 2012, ACS nano.

[16]  Bo Zhang,et al.  Linear polyethyleneimine-based charge-reversal nanoparticles for nuclear-targeted drug delivery , 2011 .

[17]  T. Park,et al.  RGD targeting hyaluronic acid coating system for PEI-PBLG polycation gene carriers. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[18]  Gert Storm,et al.  Endosomal escape pathways for delivery of biologicals. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[19]  K. High,et al.  Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges , 2011, Nature Reviews Genetics.

[20]  Min Zhang,et al.  Multifunctional Triblock Nanocarrier (PAMAM-PEG-PLL) for the Efficient Intracellular siRNA Delivery and Gene Silencing , 2011, ACS nano.

[21]  X. Shuai,et al.  Polyethylenimine-grafted copolymer of poly(l-lysine) and poly(ethylene glycol) for gene delivery. , 2011, Biomaterials.

[22]  H. Luhmann,et al.  Fine-tuning DNA/albumin polyelectrolyte interactions to produce the efficient transfection agent cBSA-147. , 2010, Biomaterials.

[23]  Qiao Jiang,et al.  Enhanced gene delivery and siRNA silencing by gold nanoparticles coated with charge-reversal polyelectrolyte. , 2010, ACS nano.

[24]  Xing-jie Liang,et al.  Poly(ε-caprolactone)-graft-poly(2-(N,N-dimethylamino) ethyl methacrylate) nanoparticles: pH dependent thermo-sensitive multifunctional carriers for gene and drug delivery , 2010 .

[25]  S. Kawakami,et al.  Gamma-polyglutamic acid-coated vectors for effective and safe gene therapy. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[26]  Yang Huang,et al.  The use of PEGylated poly [2-(N,N-dimethylamino) ethyl methacrylate] as a mucosal DNA delivery vector and the activation of innate immunity and improvement of HIV-1-specific immune responses. , 2010, Biomaterials.

[27]  L. J. Lee,et al.  Efficient delivery of antisense oligodeoxyribonucleotide g3139 by human serum albumin-coated liposomes. , 2009, Molecular pharmaceutics.

[28]  N. Ballal,et al.  A comparative in vitro evaluation of cytotoxic effects of EDTA and maleic acid: root canal irrigants. , 2009, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[29]  H. Sasaki,et al.  Ternary complexes of pDNA, polyethylenimine, and gamma-polyglutamic acid for gene delivery systems. , 2009, Biomaterials.

[30]  Meredith A Mintzer,et al.  Nonviral vectors for gene delivery. , 2009, Chemical reviews.

[31]  Y. Bae,et al.  pH‐Tunable Endosomolytic Oligomers for Enhanced Nucleic Acid Delivery , 2007 .

[32]  A. Schätzlein,et al.  Dendrimers in gene delivery. , 2005, Advanced drug delivery reviews.

[33]  Yan Zhang,et al.  Cationic albumin-conjugated pegylated nanoparticles as novel drug carrier for brain delivery. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[34]  Steven G Potkin,et al.  A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease , 2005, Nature Medicine.

[35]  A. El-Aneed,et al.  An overview of current delivery systems in cancer gene therapy. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[36]  D. Fischer,et al.  A Novel Non-Viral Vector for DNA Delivery Based on Low Molecular Weight, Branched Polyethylenimine: Effect of Molecular Weight on Transfection Efficiency and Cytotoxicity , 1999, Pharmaceutical Research.

[37]  H. von Briesen,et al.  Human serum albumin-polyethylenimine nanoparticles for gene delivery. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[38]  Thomas Kissel,et al.  In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis. , 2003, Biomaterials.

[39]  G. Amidon,et al.  Enhanced cytosolic delivery of plasmid DNA by a sulfhydryl-activatable listeriolysin O/protamine conjugate utilizing cellular reducing potential , 2003, Gene Therapy.

[40]  A. Klibanov,et al.  Enhancing polyethylenimine's delivery of plasmid DNA into mammalian cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[41]  T. Bieber,et al.  Intracellular route and transcriptional competence of polyethylenimine-DNA complexes. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[42]  T. Park,et al.  A new gene delivery formulation of polyethylenimine/DNA complexes coated with PEG conjugated fusogenic peptide. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[43]  E. Wagner,et al.  Polyethylenimine/DNA complexes shielded by transferrin target gene expression to tumors after systemic application , 2001, Gene Therapy.

[44]  F. Deist,et al.  Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. , 2000, Science.

[45]  W. Hennink,et al.  Copolymers of 2-(dimethylamino)ethyl methacrylate with ethoxytriethylene glycol methacrylate or N-vinyl-pyrrolidone as gene transfer agents. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[46]  S. Ylä-Herttuala,et al.  Cardiovascular gene therapy , 2000, The Lancet.

[47]  M. Ogris,et al.  PEGylated DNA/transferrin–PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery , 1999, Gene Therapy.

[48]  I Mellman,et al.  Acidification of the endocytic and exocytic pathways. , 1986, Annual review of biochemistry.